Neurofibromatosis Type 1 Tumor Early Detection Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neurofibromatosis Type 1 Tumor Early Detection Study — Stella

Recruiting

Back to Neurofibromatosis Type 1 trials

Trial locations(1 site)

United States

Boston Children's Hospital, Boston, Massachusetts

Key details

Sponsor

David Miller

Enrollment target

~1,000 participants

Started

August 2024

Primary completion

July 2030

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov